LSI's Medtech Start-Up Tracker is focused exclusively on covering the privately-held innovators changing the medical device landscape.
Novel molecular diagnostics for the detection of acute infections and sepsis from Inflammatix
Using proprietary machine learning algorithms, Inflammatix’s HostDx InSep and HostDx Fever are rapid point-of-care tests capable of producing results in 30 minutes or less. Inflammatix has successfully raised an estimated $33M in funding since its founding in 2016. Key competitors in the point of care diagnostics market include Abbott, BD, and Roche.